Expression of estrogen-metabolizing enzymes and estrogen receptors in cholelithiasis gallbladder

被引:6
作者
Svoboda, Martin [2 ]
Sellner, Franz [4 ]
Ekmekcioglu, Cem [1 ]
Klimpfinger, Martin [4 ]
Jaeger, Walter [3 ]
Thalhammer, Theresia [2 ]
机构
[1] Med Univ Vienna, Inst Physiol, Ctr Physiol Pathophysiol & Immunol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Inst Pathophysiol, Ctr Physiol Pathophysiol & Immunol, A-1090 Vienna, Austria
[3] Univ Vienna, Inst Clin Pharm & Diagnost, A-1010 Vienna, Austria
[4] Kaiser Franz Josef Spital, Inst Pathol & Bacteriol, Vienna, Austria
关键词
Estrogen-sulfotransferase; Steroid sulfatase; Estrogen receptor; Gallbladder; Cholelithiasis; Inflammation;
D O I
10.1016/j.biopha.2008.03.007
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Estrogen exposure is a risk factor for gallstone disease (cholelithiasis), which often leads to chronic inflammation (cholecystitis). Studies in various estrogen-sensitive tissues showed that key enzymes involved in the inactivation and activation of estrogens as well as expression of estrogen receptors a and R determine the amount of active estrogen. In estrogen-sensitive tissues, e.g. the female breast, estrone sulfate (E IS), present at high concentrations in the circulation, is converted into the biologically active estrone (E1) by steroid sulfatase (STS) and again reverted into EIS by estrogen sulfotransferase (SULT1E1) providing a local estrogen storage. Aims: To assess whether this might also apply for gallbladder epithelia, we determined expression of these two enzymes and of ER alpha and ER beta in 15 cholelithiasis specimens from tissues with/or without inflammation. Methods: Quantitative (Real-time) PCR and immunofluorescence were used as methods. Results: We demonstrate mRNA expression of SULT1E1, STS, and ERa in all specimens with mean enrichment of 3.53- vs. 1.72-fold (n.s.), 3.5- vs. 0.91-fold (n.s.), and 3.04- vs. 1.6-fold (n.s.) in the inflammatory and non-inflammatory groups, respectively. Although high expression levels were seen in many specimens (means 4.88-fold vs. 5.77-fold), ERR mRNA was below the detection limit in two specimens from cholecystitis patients. To further investigate this varying expression pattern of ERR, immunohistological studies were performed, which indeed showed low expression levels of ERR in the damaged mucosa, while in specimens with well preserved mucosa, high ERR levels were seen in the cytosol and in the nucleus. Conclusion: The data show expression of an estrogen network of activating STS and inactivating SULT1E1 Together with ER alpha and ER beta, these enzymes could regulate estrogen concentrations in human gallbladder. (c) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:690 / 696
页数:7
相关论文
共 39 条
[1]   Regulation and deregulation of cholangiocyte proliferation [J].
Alvaro, D ;
Gigliozzi, A ;
Attili, AF .
JOURNAL OF HEPATOLOGY, 2000, 33 (02) :333-340
[2]   Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium [J].
Aust, S ;
Obrist, P ;
Jaeger, W ;
Klimpfinger, M ;
Tucek, G ;
Wrba, F ;
Penner, E ;
Thalhammer, T .
LABORATORY INVESTIGATION, 2004, 84 (08) :1024-1036
[3]   Inflammatory status influences aromatase and steroid receptor expression in endometriosis [J].
Bukulmez, Orhan ;
Hardy, Daniel B. ;
Carr, Bruce R. ;
Word, R. Ann ;
Mendelson, Carole R. .
ENDOCRINOLOGY, 2008, 149 (03) :1190-1204
[4]   Identification of pathway-selective estrogen receptor ligands that inhibit NF-κ3 transcriptional activity [J].
Chadwick, CC ;
Chippari, S ;
Matelan, E ;
Borges-Marcucci, L ;
Eckert, AM ;
Keith, JC ;
Albert, LM ;
Leathurby, Y ;
Harris, HA ;
Bhat, RA ;
Ashwell, M ;
Trybulski, E ;
Winneker, RC ;
Adeknab, SJ ;
Steffan, RJ ;
Harnish, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) :2543-2548
[5]   Estrogen receptors α and β are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice [J].
Cho, Nancy L. ;
Javid, Sara H. ;
Carothers, Adelaide M. ;
Redston, Mark ;
Bertagnolli, Monica M. .
CANCER RESEARCH, 2007, 67 (05) :2366-2372
[6]   Effect of estrogen therapy on gallbladder disease [J].
Cirillo, DJ ;
Wallace, RB ;
Rodabough, RJ ;
Greenland, P ;
LaCroix, AZ ;
Limacher, MC ;
Larson, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (03) :330-339
[7]   International Union of Pharmacology.: LXIV.: Estrogen receptors [J].
Dahlman-Wright, Karin ;
Cavailles, Vincent ;
Fuqua, Suzanne A. ;
Jordan, V. Craig ;
Katzenellenbogen, John A. ;
Korach, Kenneth S. ;
Maggi, Adriana ;
Muramatsu, Masami ;
Parker, Malcolm G. ;
Gustafsson, Jan-Ake .
PHARMACOLOGICAL REVIEWS, 2006, 58 (04) :773-781
[8]  
Falany CN, 1997, FASEB J, V11, P1
[9]  
Falany JL, 1997, ONCOL RES, V9, P589
[10]   What pharmacologists can learn from recent advances in estrogen signalling [J].
Gustaftson, JÅ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (09) :479-485